Myomar Molecular is developing a diagnostic tool that utilizes molecular biomarkers to assess muscle metabolism and identify early stages of muscle atrophy. This technology provides personalized action plans to enhance fitness performance, recovery, and muscle growth, addressing the critical need for early detection of muscle health issues.
Funding
$810.1K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NSFounders
Product
Problem
Current methods for assessing muscle health often rely on late-stage indicators of atrophy, lacking the sensitivity to detect subtle metabolic changes that precede significant muscle decline. This makes it difficult to implement early interventions for optimizing fitness performance, recovery, and muscle growth.
Solution
Myomar Molecular is developing a diagnostic tool that uses molecular biomarkers to provide a comprehensive assessment of muscle metabolism. By analyzing these biomarkers, the tool identifies early indicators of muscle health issues, allowing for personalized action plans to optimize fitness performance and recovery. The diagnostic approach is tailored to an individual's unique molecular profile, enabling targeted interventions to sustain optimal muscle health. This enables users to proactively manage their muscle health and performance through data-driven insights.
Target Audience
The primary target audience includes athletes, fitness enthusiasts, and individuals in physiotherapy clinics seeking to optimize muscle health, performance, and recovery through personalized, data-driven insights.
Features
- Analysis of key biomarkers related to muscle performance, nutrition, efficiency, and recovery
- Personalized action plans based on individual molecular biomarker profiles
- Identification of metabolic stress and fatigue indicators
- Monitoring of biomarkers influencing muscle mass and strength
- Assessment of energy conversion efficiency for strength and power
- Evaluation of biomarkers associated with endurance capacity and muscle fatigue reduction